Provide high-purity and highly stable intermediate 29 peptide of semaglutide, equipped with comprehensive technical support services, to help customers improve efficiency and reduce costs, accelerate industrial layout without animal sources, and ensure safety.

The use of E. coli recombinant expression system eliminates animal source risks from the source, ensures the safety and stable supply of raw materials, and effectively avoids potential risks of viruses, viruses, and exogenous pathogens, meeting higher standards for drug development and production requirements.Fermentation semi synthetic process, higher purity.

By using a recombinant expression system of Escherichia coli, the risk of animal sources is eliminated from the source, ensuring the safety and stable supply of raw materials, and effectively avoiding potential risks of viruses, viruses, and exogenous pathogens, meeting higher standards for drug development and production requirements. Self developed raw materials, controllable quality, and consistency between batches.

By using a recombinant expression system of Escherichia coli, the risk of animal origin is eliminated from the source, ensuring the safety and stable supply of raw materials, and effectively avoiding potential risks of viruses, prions, and exogenous pathogens, meeting higher standards for drug development and production requirements.